Knockdown of Salusin‐β Downregulates FTO to Inhibit Lipid Synthesis and Promote Lipolysis to Attenuate NAFLD
Liver International · 2025
DOI: 10.1111/liv.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Jintong Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Non-alcoholic Fatty Liver Disease, Intercellular Signaling Peptides and Proteins, Lipolysis. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Department of Higher Education, Ministry of Education, industry-university cooperative education project..
Abstract (Originalsprache)
Background
Non‐alcoholic fatty liver disease is now a significant public health issue globally. Salusin‐β, a vasoactive peptide, plays a role in lipid metabolism regulation, but its mechanism remains unreported.
Methods
We studied the effects of Salusin‐β on lipid metabolism and its mechanism by creating a NAFLD model in C57BL/6J mice and inducing steatosis in HepG2 cells. Then, shSalusin‐β lentivirus was applied to transfect into the animals and cells, and the degree of lipid accumulation was assessed by staining and various biochemical indexes. Subsequently, Semi‐Quantitative PCR, Western Blot, molecular docking, and Co‐Immunoprecipitation were utilised to probe the downstream target FTO and then to verify the protein and mRNA changes of liposynthesis and catabolism genes downstream of FTO. Overexpressed FTO lentivirus was further employed to confirm this mechanism.
Results
The results showed that knockdown of Salusin‐β significantly attenuated the degree of lipid accumulation in mice and cells. In addition, shSalusin‐β inhibited the expression of FTO, thereby inhibiting the expression of downstream sterol regulatory element binding protein‐1c, fatty acid synthase, and promoting the expression of peroxisome proliferators‐activated receptors α and carnitine palmitoyl transferase 1. Transfection of overexpressed FTO then eliminated the regulatory effect of shSalusin‐β on downstream molecules.
Conclusions
In conclusion, knockdown of Salusin‐β reduced FTO production, thereby alleviating lipid metabolism disorders. This provides a potential mechanism for elucidating the reduction of lipid metabolism by knockdown of Salusin‐β and a potential target for the treatment of NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- Department of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- Department of Spleen and Gastroenterology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
ORCID-Profile: Jintong Pan
Förderung
- Department of Higher Education, Ministry of Education, industry-university cooperative education project.
Zitieren
APA
Pan, J., Ye, W., Zhang, J., Fan, Y., Chen, Z., Wang, Y., & Liu, X. (2025). Knockdown of Salusin‐β Downregulates FTO to Inhibit Lipid Synthesis and Promote Lipolysis to Attenuate NAFLD. Liver International. https://doi.org/10.1111/liv.70252
Vancouver
Pan J, Ye W, Zhang J, Fan Y, Chen Z, Wang Y, et al. Knockdown of Salusin‐β Downregulates FTO to Inhibit Lipid Synthesis and Promote Lipolysis to Attenuate NAFLD. Liver International. 2025. doi:10.1111/liv.70252
BibTeX
@article{Pan2025,
author = {Pan, Jintong and Ye, Wei and Zhang, Jinmeng and Fan, Ye and Chen, Zaohong and Wang, Yuxue and Liu, Xiang},
title = {Knockdown of Salusin‐β Downregulates FTO to Inhibit Lipid Synthesis and Promote Lipolysis to Attenuate NAFLD},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70252}
}
EUVIMED